Shanghai GenTech Co., Ltd. announced that it expects to receive CNY 300 million in funding from Caitong Fund Management Co., Ltd., Nuode Asset Management Co., Ltd., Shenzhen Niufusi Investment Co., Ltd.
May 26, 2022
Share
Shanghai GenTech Co., Ltd. announced a private placement of A shares for gross proceeds not more than CNY 300,000,000 on May 27, 2022. The issue price shall not be lower than 80% of the average stock trading price of the 20 trading days prior to the pricing benchmark date. The transaction will include participation from not more than 35 investors.
The transaction has been approved in the 11th meeting of the 3rd board of directors. The transaction is subject to approval of Shanghai Stock Exchange and China Securities Regulatory Commission. All securities issued in the transaction have a hold period of 18 months.
Shanghai GenTech Co Ltd is a China-based company that provides comprehensive solutions for process media and process environment. Its main businesses are divided into three categories. The design, production, installation and supporting business of gas chemical supply system provide products which include special gas tanks, shunt boxes, liquid source conveying equipment, pharmaceutical liquid mixing units, etc. The main products of the production and sales of high-purity specialty gases business include arsine, phosphorane, silane and mixed gases. The design and construction of the supporting system of the clean plant business include clean room air conditioning systems, air filtration systems and interior decoration, as well as process cooling water systems, clean compressed air systems and vacuum systems. Its products are used in industries such as pan-semiconductor, optical fiber communications and pharmaceutical manufacturing.
Shanghai GenTech Co., Ltd. announced that it expects to receive CNY 300 million in funding from Caitong Fund Management Co., Ltd., Nuode Asset Management Co., Ltd., Shenzhen Niufusi Investment Co., Ltd.
SHANGHAI GENTECH CO., LTD. 
